Kemal Bayrakçeken, Rukiye Kilic Ucgul, Taha Coban, Gulce Yazıcı, Halis Suleyman
{"title":"三磷酸腺苷对胺碘酮诱导大鼠视神经病变的影响:生化和组织病理学评价。","authors":"Kemal Bayrakçeken, Rukiye Kilic Ucgul, Taha Coban, Gulce Yazıcı, Halis Suleyman","doi":"10.1080/15569527.2023.2227265","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aims to investigate possible preventive effect of ATP on optic nerve damage caused by amiodarone in rats.</p><p><strong>Material and method: </strong>Thirty albino male Wistar rats weighing between 265 and 278 g were used in the study. Before the experiment, the rats were housed at 22 °C in a 12-h light/dark cycle under appropriate condition. The rats were equally divided into five groups of six animals each: healthy group, 50 mg/kg amiodarone (AMD-50), 100 mg/kg amiodarone (AMD-100), 25 mg/kg ATP + 50 mg/kg amiodarone (ATAD-50), and 25 mg/kg ATP + 100 mg/kg amiodarone (ATAD-100). At the end of 14th day, the animals were sacrificed using cardiac puncture under deep thiopental anaesthesia, and optic nerve tissues were harvested to measure superoxide dismutase (SOD), total glutathione (tGSH), malondialdehyde (MDA), and catalase (CAT) levels.</p><p><strong>Results: </strong>The MDA levels were found to be significantly higher in the AMD-50 and AMD-100 groups compared to the healthy group (<i>p</i> ˂ 0.001). There was also a significant difference between the AMD-50 and ATAD-50 groups, and between the AMD-100 and ATAD-100 groups regarding MDA levels (<i>p</i> ˂ 0.001). tGSH, SOD, and CAT levels were significantly lower in the AMD-50 and AMD-100 groups compared to the healthy group (<i>p</i> ˂ 0.001). ATP was found to partially inhibit amiodarone-induced optic neuropathy.</p><p><strong>Conclusion: </strong>The biochemical and histopathological results of this study demonstrated that amiodarone at high doses caused more severe optic neuropathy inducing oxidative damage, but ATP could relatively antagonise these negative effects on the optic nerve. Therefore, we believe that ATP may be beneficial in preventing amiodarone-induced optic neuropathy.</p>","PeriodicalId":11023,"journal":{"name":"Cutaneous and Ocular Toxicology","volume":"42 3","pages":"162-167"},"PeriodicalIF":1.6000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effect of adenosine triphosphate on amiodarone-induced optic neuropathy in rats: biochemical and histopathological evaluation.\",\"authors\":\"Kemal Bayrakçeken, Rukiye Kilic Ucgul, Taha Coban, Gulce Yazıcı, Halis Suleyman\",\"doi\":\"10.1080/15569527.2023.2227265\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>This study aims to investigate possible preventive effect of ATP on optic nerve damage caused by amiodarone in rats.</p><p><strong>Material and method: </strong>Thirty albino male Wistar rats weighing between 265 and 278 g were used in the study. Before the experiment, the rats were housed at 22 °C in a 12-h light/dark cycle under appropriate condition. The rats were equally divided into five groups of six animals each: healthy group, 50 mg/kg amiodarone (AMD-50), 100 mg/kg amiodarone (AMD-100), 25 mg/kg ATP + 50 mg/kg amiodarone (ATAD-50), and 25 mg/kg ATP + 100 mg/kg amiodarone (ATAD-100). At the end of 14th day, the animals were sacrificed using cardiac puncture under deep thiopental anaesthesia, and optic nerve tissues were harvested to measure superoxide dismutase (SOD), total glutathione (tGSH), malondialdehyde (MDA), and catalase (CAT) levels.</p><p><strong>Results: </strong>The MDA levels were found to be significantly higher in the AMD-50 and AMD-100 groups compared to the healthy group (<i>p</i> ˂ 0.001). There was also a significant difference between the AMD-50 and ATAD-50 groups, and between the AMD-100 and ATAD-100 groups regarding MDA levels (<i>p</i> ˂ 0.001). tGSH, SOD, and CAT levels were significantly lower in the AMD-50 and AMD-100 groups compared to the healthy group (<i>p</i> ˂ 0.001). ATP was found to partially inhibit amiodarone-induced optic neuropathy.</p><p><strong>Conclusion: </strong>The biochemical and histopathological results of this study demonstrated that amiodarone at high doses caused more severe optic neuropathy inducing oxidative damage, but ATP could relatively antagonise these negative effects on the optic nerve. Therefore, we believe that ATP may be beneficial in preventing amiodarone-induced optic neuropathy.</p>\",\"PeriodicalId\":11023,\"journal\":{\"name\":\"Cutaneous and Ocular Toxicology\",\"volume\":\"42 3\",\"pages\":\"162-167\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cutaneous and Ocular Toxicology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/15569527.2023.2227265\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cutaneous and Ocular Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15569527.2023.2227265","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:探讨ATP对胺碘酮致大鼠视神经损伤的预防作用。材料与方法:选用体重265 ~ 278 g的雄性白化Wistar大鼠30只。实验前,在适宜条件下,将大鼠置于22°C, 12h明暗循环。将大鼠平均分为5组,每组6只:健康组、50 mg/kg胺碘酮(AMD-50)、100 mg/kg胺碘酮(AMD-100)、25 mg/kg ATP + 50 mg/kg胺碘酮(ATAD-50)、25 mg/kg ATP + 100 mg/kg胺碘酮(ATAD-100)。第14天结束时,在硫透钠深度麻醉下穿刺处死大鼠,取视神经组织测定超氧化物歧化酶(SOD)、总谷胱甘肽(tGSH)、丙二醛(MDA)和过氧化氢酶(CAT)水平。结果:与健康组相比,AMD-50和AMD-100组的MDA水平显著升高(p小于0.001)。在MDA水平方面,AMD-50组和ATAD-50组之间以及AMD-100组和ATAD-100组之间也存在显著差异(p小于0.001)。与健康组相比,AMD-50和AMD-100组的tGSH、SOD和CAT水平显著降低(p小于0.001)。发现ATP部分抑制胺碘酮诱导的视神经病变。结论:本研究的生化和组织病理学结果表明,高剂量胺碘酮引起更严重的视神经病变和氧化损伤,而ATP可以相对拮抗这些负面影响。因此,我们认为ATP可能有助于预防胺碘酮诱导的视神经病变。
Effect of adenosine triphosphate on amiodarone-induced optic neuropathy in rats: biochemical and histopathological evaluation.
Objective: This study aims to investigate possible preventive effect of ATP on optic nerve damage caused by amiodarone in rats.
Material and method: Thirty albino male Wistar rats weighing between 265 and 278 g were used in the study. Before the experiment, the rats were housed at 22 °C in a 12-h light/dark cycle under appropriate condition. The rats were equally divided into five groups of six animals each: healthy group, 50 mg/kg amiodarone (AMD-50), 100 mg/kg amiodarone (AMD-100), 25 mg/kg ATP + 50 mg/kg amiodarone (ATAD-50), and 25 mg/kg ATP + 100 mg/kg amiodarone (ATAD-100). At the end of 14th day, the animals were sacrificed using cardiac puncture under deep thiopental anaesthesia, and optic nerve tissues were harvested to measure superoxide dismutase (SOD), total glutathione (tGSH), malondialdehyde (MDA), and catalase (CAT) levels.
Results: The MDA levels were found to be significantly higher in the AMD-50 and AMD-100 groups compared to the healthy group (p ˂ 0.001). There was also a significant difference between the AMD-50 and ATAD-50 groups, and between the AMD-100 and ATAD-100 groups regarding MDA levels (p ˂ 0.001). tGSH, SOD, and CAT levels were significantly lower in the AMD-50 and AMD-100 groups compared to the healthy group (p ˂ 0.001). ATP was found to partially inhibit amiodarone-induced optic neuropathy.
Conclusion: The biochemical and histopathological results of this study demonstrated that amiodarone at high doses caused more severe optic neuropathy inducing oxidative damage, but ATP could relatively antagonise these negative effects on the optic nerve. Therefore, we believe that ATP may be beneficial in preventing amiodarone-induced optic neuropathy.
期刊介绍:
Cutaneous and Ocular Toxicology is an international, peer-reviewed journal that covers all types of harm to cutaneous and ocular systems. Areas of particular interest include pharmaceutical and medical products; consumer, personal care, and household products; and issues in environmental and occupational exposures.
In addition to original research papers, reviews and short communications are invited, as well as concise, relevant, and critical reviews of topics of contemporary significance.